
8200 SW 117th AveSte 110Miami, FL 33183
Fax+1 305-274-5512
Overview of Dr. Friedman
Mark Friedman, MD, is a gastroenterologist based in Tampa, FL, with subspecialty expertise in screening procedures. He completed his medical education at the State University of New York Downstate Medical Center College of Medicine, followed by a residency in internal medicine at George Washington University and a fellowship in gastroenterology at Albany Medical Center. Dr. Friedman has experience in general gastroenterology and hepatology. His publications include several articles in peer-reviewed journals, reflecting his contributions to conditions such as hepatitis C, melanoma of the esophagus, inflammatory bowel disease, and colorectal cancer. Additionally, he received a Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.
Education & Training
- Albany Medical CenterFellowship, Gastroenterology, 2008 - 2011
- George Washington UniversityResidency, Internal Medicine, 2005 - 2008
- State University of New York Downstate Medical Center College of MedicineClass of 2005
Certifications & Licensure
- FL State Medical License 2011 - 2027
- DC State Medical License 2005 - 2008
- VA State Medical License 2005 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Self-Assembling Hemostatic Peptide Gel Used to Successfully Treat Rectal Ulcer in Radiation-Associated Vascular Ectasia: A Case Report.Rishi Bolla, Shaffer Mok, Mark Friedman, Aamir Dam, Anjuli K Luthra
The American Journal of Case Reports. 2025-03-17 - 1 citationsElevated Urinary Levels of Fungal and Environmental Toxins in Patients with Pancreatic Ductal Adenocarcinoma.Vanessa I Rodriguez, Jamila Mammadova, Jennifer B Permuth, Anjuli Luthra, Luis Pena
Journal of Gastrointestinal Cancer. 2024-10-17 - Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals.Zachary Makovich, Ivana Radosavljevic, Shreya Chapyala, Guy Handley, Luis Pena
Digestive Diseases and Sciences. 2024-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: